Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study.

Trial Profile

Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 May 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Ischaemic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2015 Planned End Date changed from 1 Jul 2009 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 07 May 2015 Planned primary completion date changed from 1 Jun 2009 to 1 May 2015 as reported by ClinicalTrials.gov record.
    • 07 May 2008 The expected completion date for this trial has been extended from Jul 2008 to Jul 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top